{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T21:55:59Z","timestamp":1774648559069,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.cyto.2014.02.002","type":"journal-article","created":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T19:11:05Z","timestamp":1393441865000},"page":"13-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Antimalarial drugs inhibit IFN\u03b1-enhanced TNF\u03b1 and STAT4 expression in monocytes: Implication for systemic lupus erythematosus"],"prefix":"10.1016","volume":"67","author":[{"given":"Patricia","family":"L\u00f3pez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Rodr\u00edguez-Carrio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2014.02.002_b0005","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1126\/science.1064890","article-title":"Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus","volume":"294","author":"Blanco","year":"2001","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.cyto.2014.02.002_b0010","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.clim.2008.07.010","article-title":"IFNalpha treatment generates antigen-presenting cells insensitive to atorvastatin inhibition of MHC-II expression","volume":"129","author":"L\u00f3pez","year":"2008","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.cyto.2014.02.002_b0015","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1074-7613(03)00208-5","article-title":"Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6","volume":"19","author":"Jego","year":"2003","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.cyto.2014.02.002_b0020","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/03009734.2011.624649","article-title":"The type I interferon system in the etiopathogenesis of autoimmune diseases","volume":"116","author":"R\u00f6nnblom","year":"2011","journal-title":"Ups J Med Sci"},{"issue":"5","key":"10.1016\/j.cyto.2014.02.002_b0025","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1073\/pnas.0337679100","article-title":"Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus","volume":"100","author":"Baechler","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.cyto.2014.02.002_b0030","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/ar1015","article-title":"Microarray analysis of gene expression in lupus","volume":"5","author":"Crow","year":"2003","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.cyto.2014.02.002_b0035","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1471-4906(01)01955-X","article-title":"An etiopathogenic role for the type I IFN system in SLE","volume":"22","author":"R\u00f6nnblom","year":"2001","journal-title":"Trends Immunol"},{"issue":"8","key":"10.1016\/j.cyto.2014.02.002_b0040","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1084\/jem.20050914","article-title":"Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus","volume":"202","author":"Barrat","year":"2005","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.cyto.2014.02.002_b0045","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1172\/JCI23025","article-title":"Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9","volume":"115","author":"Means","year":"2005","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.cyto.2014.02.002_b0050","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.molimm.2006.10.006","article-title":"Pre-assembly of STAT4 with the human IFN-alpha\/beta receptor-2 subunit is mediated by the STAT4 N-domain","volume":"44","author":"Tyler","year":"2007","journal-title":"Mol Immunol"},{"issue":"5","key":"10.1016\/j.cyto.2014.02.002_b0055","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.immuni.2008.08.017","article-title":"Signal transducer and activator of transcription 4 is required for the transcription factor T-bet to promote T helper 1 cell-fate determination","volume":"29","author":"Thieu","year":"2008","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.cyto.2014.02.002_b0060","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMoa073003","article-title":"STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus","volume":"357","author":"Remmers","year":"2007","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.cyto.2014.02.002_b0065","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1093\/hmg\/ddn184","article-title":"A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5","volume":"17","author":"Sigurdsson","year":"2008","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.cyto.2014.02.002_b0070","doi-asserted-by":"crossref","first-page":"e1000084","DOI":"10.1371\/journal.pgen.1000084","article-title":"Specificity of the STAT4 genetic association for severe disease manifestations of systemic lupus erythematosus","volume":"4","author":"Taylor","year":"2008","journal-title":"PLoS Genet"},{"issue":"10","key":"10.1016\/j.cyto.2014.02.002_b0075","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1002\/art.22156","article-title":"Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus","volume":"54","author":"Costedoat-Chalumeau","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"01","key":"10.1016\/j.cyto.2014.02.002_b0080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/ard.2008.101766","article-title":"Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review","volume":"69","author":"Ruiz-Irastorza","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.cyto.2014.02.002_b0085","first-page":"122","article-title":"Chloroquine inhibits macrophage tumour necrosis factor-alpha mRNA transcription","volume":"80","author":"Zhu","year":"1993","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.cyto.2014.02.002_b0090","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.4049\/jimmunol.165.3.1534","article-title":"Chloroquine interferes with lipopolysaccharide-induced TNF-alpha gene expression by a nonlysosomotropic mechanism","volume":"165","author":"Weber","year":"2000","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.cyto.2014.02.002_b0095","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.4049\/jimmunol.168.10.5303","article-title":"Inhibition of mitogen-activated protein kinase signaling by chloroquine","volume":"168","author":"Weber","year":"2002","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.cyto.2014.02.002_b0100","doi-asserted-by":"crossref","first-page":"R42","DOI":"10.1186\/ar1897","article-title":"Cytokine polymorphisms influence treatment outcomes in SLE patients treated with antimalarial drugs","volume":"8","author":"L\u00f3pez","year":"2006","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.cyto.2014.02.002_b0105","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1191\/0961203306lu2299oa","article-title":"Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients","volume":"15","author":"Wozniacka","year":"2006","journal-title":"Lupus"},{"issue":"10","key":"10.1016\/j.cyto.2014.02.002_b0110","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1002\/art.22157","article-title":"Antimalarial agents: closing the gate on Toll-like receptors?","volume":"54","author":"Lafyatis","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.cyto.2014.02.002_b0115","first-page":"1559","article-title":"Influence of functional interleukin 10\/tumor necrosis factor-alpha polymorphisms on interferon-alpha, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment","volume":"35","author":"L\u00f3pez","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cyto.2014.02.002_b0120","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1002\/art.34483","article-title":"Large scale analysis of tumor necrosis factor alpha levels in systemic lupus erythematosus","volume":"64","author":"Weckerle","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.cyto.2014.02.002_b0125","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1191\/0961203302lu160oa","article-title":"Increased bioactive TNF in human systemic lupus erythematosus: associations with cell death","volume":"11","author":"Aringer","year":"2002","journal-title":"Lupus"},{"issue":"1\u20132","key":"10.1016\/j.cyto.2014.02.002_b0130","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jim.2004.03.003","article-title":"Method for large scale isolation, culture and cryopreservation of human monocytes suitable for chemotaxis, cellular adhesion assays, macrophage and dendritic cell differentiation","volume":"288","author":"Seager Danciger","year":"2004","journal-title":"J Immunol Methods"},{"issue":"3","key":"10.1016\/j.cyto.2014.02.002_b0135","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/01.md.0000224711.54886.b1","article-title":"Systemic lupus erythematosus in Asturias, Spain: clinical and serologic features","volume":"85","author":"G\u00f3mez","year":"2006","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"10.1016\/j.cyto.2014.02.002_b0140","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1191\/0961203303lu469xx","article-title":"Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features","volume":"12","author":"L\u00f3pez","year":"2003","journal-title":"Lupus"},{"issue":"11","key":"10.1016\/j.cyto.2014.02.002_b0145","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.cyto.2014.02.002_b0150","first-page":"345","article-title":"Interferon-beta not only inhibits interleukin-1beta and tumor necrosis factor-alpha but stimulates interleukin-1 receptor antagonist production in human peripheral blood mononuclear cells","volume":"8","author":"Coclet-Ninin","year":"1997","journal-title":"Eur Cytokine Network"},{"issue":"5","key":"10.1016\/j.cyto.2014.02.002_b0155","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1006\/cyto.2001.0884","article-title":"IFN-beta inhibits the ability of T lymphocytes to induce TNF-alpha and IL-1beta production in monocytes upon direct cell\u2013cell contact","volume":"14","author":"Jungo","year":"2001","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.cyto.2014.02.002_b0160","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/107999001750133113","article-title":"IFN-beta1b augments glucocorticoid-induced suppression of tumor necrosis factor-alpha production by increasing the number of glucocorticoid receptors on a human monocytic cell line","volume":"21","author":"Uitdehaag","year":"2001","journal-title":"J Interferon Cytokine Res"},{"issue":"12","key":"10.1016\/j.cyto.2014.02.002_b0165","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1182\/blood-2005-07-3058","article-title":"Interferons limit inflammatory responses by induction of tristetraprolin","volume":"107","author":"Sauer","year":"2006","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.cyto.2014.02.002_b0170","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1084\/jem.20051725","article-title":"Twist mediates suppression of inflammation by type I IFNs and Axl","volume":"203","author":"Sharif","year":"2006","journal-title":"J Exp Med"},{"issue":"1\u20132","key":"10.1016\/j.cyto.2014.02.002_b0175","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jneuroim.2003.10.035","article-title":"Opposite effects of IFN beta on cytokine homeostasis in LPS- and T cell contact-activated human monocytes","volume":"146","author":"Molnarfi","year":"2004","journal-title":"J Neuroimmunol"},{"issue":"5","key":"10.1016\/j.cyto.2014.02.002_b0180","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/35073080","article-title":"A weak signal for strong responses: interferon-alpha\/beta revisited","volume":"2","author":"Taniguchi","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"10.1016\/j.cyto.2014.02.002_b0185","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1002\/art.24555","article-title":"Elevated serum interferon alpha activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after 36months of therapy","volume":"60","author":"Niewold","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.cyto.2014.02.002_b0190","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/art.24557","article-title":"Neutralization of interferon-alpha\/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus","volume":"60","author":"Yao","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.cyto.2014.02.002_b0195","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/ar3150","article-title":"Type I IFN and TNF\u03b1 cross-regulation in immune-mediated inflammatory disease: basic concepts and clinical relevance","volume":"12","author":"Cantaert","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.cyto.2014.02.002_b0200","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1084\/jem.20021553","article-title":"Interferon and granulopoiesis signatures in systemic lupus erythematosus blood","volume":"197","author":"Bennett","year":"2003","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.cyto.2014.02.002_b0205","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/rheumatology\/35.11.1067","article-title":"Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus","volume":"35","author":"Studnicka-Benke","year":"1996","journal-title":"Br J Rheumatol"},{"issue":"12","key":"10.1016\/j.cyto.2014.02.002_b0210","doi-asserted-by":"crossref","first-page":"F59","DOI":"10.1084\/jem.194.12.f59","article-title":"A pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus","volume":"194","author":"R\u00f6nnblom","year":"2001","journal-title":"J Exp Med"},{"issue":"7086","key":"10.1016\/j.cyto.2014.02.002_b0215","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature04641","article-title":"IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9","volume":"440","author":"Hoshino","year":"2006","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.cyto.2014.02.002_b0220","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/1529-0131(200003)43:3<608::AID-ANR18>3.0.CO;2-G","article-title":"Induction of tumor necrosis factor alpha production by adhered human monocytes: a key role for Fcgamma receptor type IIIa in rheumatoid arthritis","volume":"43","author":"Abrahams","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.cyto.2014.02.002_b0225","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/ni1576","article-title":"TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes","volume":"9","author":"Yarilina","year":"2008","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.cyto.2014.02.002_b0230","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1056\/NEJM199101173240303","article-title":"A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus","volume":"324","author":"The Canadian Hydroxychloroquine Study Group","year":"1991","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.cyto.2014.02.002_b0235","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1002\/art.21893","article-title":"Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sj\u00f6gren\u2019s syndrome autoantigen-associated RNA","volume":"54","author":"L\u00f6vgren","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.cyto.2014.02.002_b0240","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/ar2382","article-title":"Dysfunctional interferon-\u03b1 production by peripheral plasmacytoid dendritic cells upon Toll-like receptor-9 stimulation in patients with systemic lupus erythematosus","volume":"10","author":"Kwok","year":"2008","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.cyto.2014.02.002_b0245","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1128\/AAC.01246-09","article-title":"Chloroquine modulates HIV-1-induced plasmacytoid dendritic cell alpha interferon: implication for T-cell activation","volume":"54","author":"Martinson","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.cyto.2014.02.002_b0250","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1177\/0961203312437270","article-title":"Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort","volume":"21","author":"Willis","year":"2012","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.cyto.2014.02.002_b0255","doi-asserted-by":"crossref","first-page":"R155","DOI":"10.1186\/ar3895","article-title":"Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus","volume":"14","author":"Sacre","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"10.1016\/j.cyto.2014.02.002_b0260","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.4049\/jimmunol.164.9.4659","article-title":"Stat4 is expressed in activated peripheral blood monocytes, dendritic cells, and macrophages at sites of Th1-mediated inflammation","volume":"164","author":"Frucht","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.02.002_b0265","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4049\/jimmunol.182.1.34","article-title":"Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-\u03b1 in lupus patients in vivo","volume":"182","author":"Kariuki","year":"2009","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.cyto.2014.02.002_b0270","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.smim.2006.12.004","article-title":"TLR signaling","volume":"19","author":"Kawai","year":"2007","journal-title":"Semin Immunol"},{"issue":"11","key":"10.1016\/j.cyto.2014.02.002_b0275","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1136\/ard.2008.097642","article-title":"STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk","volume":"68","author":"Abelson","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.cyto.2014.02.002_b0280","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/art.30187","article-title":"Network analysis of associations between serum interferon-\u03b1 activity, autoantibodies, and clinical features in systemic lupus erythematosus","volume":"63","author":"Weckerle","year":"2011","journal-title":"Arthritis Rheum"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466614000313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466614000313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T09:59:17Z","timestamp":1538819957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466614000313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S1043466614000313"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2014.02.002","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimalarial drugs inhibit IFN\u03b1-enhanced TNF\u03b1 and STAT4 expression in monocytes: Implication for systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2014.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}